Sanguinaria Composé 3 Ch Globules ; Granules ; Liquid is a Health Canada–registered human drug (DIN 02236439) held by Dolisos Canada Inc., containing Spigelia Anthelmia. Health Canada lists its status as Cancelled Post Market (status date 18 Jul 2006). Nexara Health has matched 17 registrations of Spigelia Anthelmia across 3 other regulated markets, 2 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02236439 |
|---|---|
| Brand name | Sanguinaria Composé |
| Active ingredient | Spigelia Anthelmia |
| Strength | 3 Ch |
| Dosage form | Globules ; Granules ; Liquid |
| Route | Oral |
| Company | Dolisos Canada Inc. |
| Status | Cancelled Post Market — 18 Jul 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Spigelia Anthelmia registered in other markets
17 registrations of the same molecule in 3 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Spigelia Anthelmia | Herbamed AG | Liquid | FDA NDC | ||
| United States | Spigelia Anthelmia | Herbamed AG | Liquid | FDA NDC | ||
| Netherlands | Spigelia anthelmia | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| Netherlands | Spigelia anthelmia | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| United Arab Emirates | Spigelia Anthelmia - Boiron | BOIRON, France, Messimy | 1 DH - 200 CH | Pillules | Active | EDE |
| United States | Spigelia anthelmia | Boiron | Pellet | listed | FDA NDC | |
| United States | Spigelia anthelmia | Boiron | Pellet | listed | FDA NDC | |
| United States | Spigelia anthelmia | Boiron | Pellet | listed | FDA NDC | |
| United States | Spigelia anthelmia | Boiron | Pellet | listed | FDA NDC | |
| United States | Spigelia Anthelmia | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Spigelia Anthelmia | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Spigelia Anthelmia worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Sanguinaria Composé (DIN 02236439) marketed in Canada?
No. Health Canada lists DIN 02236439 as Cancelled Post Market as of 18 Jul 2006.
Who holds the Canadian licence for this product?
Dolisos Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Spigelia Anthelmia registered outside Canada?
Yes — Nexara Health has matched 17 registrations in 3 other markets, including 2 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02236439, status date 2006-07-18; national medicine registries: EDE, EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02236439, status date 2006-07-18; national medicine registries: EDE, EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02236439, status date 2006-07-18; national medicine registries: EDE, EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.